R J Bio-Tech Ltd

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, COROMANDEL.BO has a market cap of 563.3B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while COROMANDEL.BO trades at ₹1,915.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas COROMANDEL.BO's P/E ratio is 23.53. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to COROMANDEL.BO's ROE of +0.21%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to COROMANDEL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check COROMANDEL.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, COROMANDEL.NS has a market cap of 562.9B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while COROMANDEL.NS trades at ₹1,918.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas COROMANDEL.NS's P/E ratio is 23.53. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to COROMANDEL.NS's ROE of +0.21%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to COROMANDEL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check COROMANDEL.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, FACT.BO has a market cap of 488.2B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while FACT.BO trades at ₹785.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas FACT.BO's P/E ratio is 1605.11. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to FACT.BO's ROE of +0.02%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to FACT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check FACT.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, FACT.NS has a market cap of 484.8B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while FACT.NS trades at ₹785.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas FACT.NS's P/E ratio is 1593.94. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to FACT.NS's ROE of +0.02%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to FACT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check FACT.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, UPL.NS has a market cap of 479.4B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while UPL.NS trades at ₹594.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas UPL.NS's P/E ratio is 27.16. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to UPL.NS's ROE of +0.05%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to UPL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check UPL.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, PIIND.NS has a market cap of 412.5B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while PIIND.NS trades at ₹2,844.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas PIIND.NS's P/E ratio is 28.45. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to PIIND.NS's ROE of +0.14%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to PIIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check PIIND.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, PIIND.BO has a market cap of 412.4B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while PIIND.BO trades at ₹2,845.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas PIIND.BO's P/E ratio is 28.43. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to PIIND.BO's ROE of +0.14%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to PIIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check PIIND.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, BAYERCROP.NS has a market cap of 208.8B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while BAYERCROP.NS trades at ₹4,743.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas BAYERCROP.NS's P/E ratio is 31.15. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to BAYERCROP.NS's ROE of +0.23%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to BAYERCROP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check BAYERCROP.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, SUMICHEM.BO has a market cap of 182B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while SUMICHEM.BO trades at ₹380.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas SUMICHEM.BO's P/E ratio is 34.24. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to SUMICHEM.BO's ROE of +0.18%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to SUMICHEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check SUMICHEM.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, SUMICHEM.NS has a market cap of 181.9B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while SUMICHEM.NS trades at ₹380.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas SUMICHEM.NS's P/E ratio is 34.25. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to SUMICHEM.NS's ROE of +0.18%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to SUMICHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check SUMICHEM.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, ATUL7.BO has a market cap of 179B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while ATUL7.BO trades at ₹7,100.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas ATUL7.BO's P/E ratio is N/A. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to ATUL7.BO's ROE of +0.10%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to ATUL7.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check ATUL7.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, CHAMBLFERT.NS has a market cap of 171B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while CHAMBLFERT.NS trades at ₹446.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas CHAMBLFERT.NS's P/E ratio is 8.93. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to CHAMBLFERT.NS's ROE of +0.22%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to CHAMBLFERT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check CHAMBLFERT.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, CHAMBLFERT.BO has a market cap of 170.8B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while CHAMBLFERT.BO trades at ₹446.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas CHAMBLFERT.BO's P/E ratio is 9.17. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to CHAMBLFERT.BO's ROE of +0.22%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to CHAMBLFERT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check CHAMBLFERT.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, EIDPARRY.BO has a market cap of 137.9B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while EIDPARRY.BO trades at ₹814.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas EIDPARRY.BO's P/E ratio is 11.98. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to EIDPARRY.BO's ROE of +0.11%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to EIDPARRY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check EIDPARRY.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, PARADEEP.BO has a market cap of 87.6B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while PARADEEP.BO trades at ₹115.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas PARADEEP.BO's P/E ratio is 10.58. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to PARADEEP.BO's ROE of +0.20%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to PARADEEP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check PARADEEP.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, PARADEEP.NS has a market cap of 87.6B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while PARADEEP.NS trades at ₹115.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas PARADEEP.NS's P/E ratio is 10.58. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to PARADEEP.NS's ROE of +0.20%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to PARADEEP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check PARADEEP.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, SHARDACROP.NS has a market cap of 78.5B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while SHARDACROP.NS trades at ₹889.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas SHARDACROP.NS's P/E ratio is 13.87. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to SHARDACROP.NS's ROE of +0.23%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to SHARDACROP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check SHARDACROP.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, SHARDACROP.BO has a market cap of 78.5B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while SHARDACROP.BO trades at ₹889.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas SHARDACROP.BO's P/E ratio is 13.87. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to SHARDACROP.BO's ROE of +0.23%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to SHARDACROP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check SHARDACROP.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, RCF.BO has a market cap of 58.9B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while RCF.BO trades at ₹115.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas RCF.BO's P/E ratio is 18.83. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to RCF.BO's ROE of +0.07%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to RCF.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check RCF.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, RCF.NS has a market cap of 58.8B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while RCF.NS trades at ₹115.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas RCF.NS's P/E ratio is 18.81. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to RCF.NS's ROE of +0.07%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to RCF.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check RCF.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, GSFC.NS has a market cap of 55.5B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while GSFC.NS trades at ₹148.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas GSFC.NS's P/E ratio is 8.01. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to GSFC.NS's ROE of +0.06%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to GSFC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check GSFC.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, GSFC.BO has a market cap of 55.5B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while GSFC.BO trades at ₹148.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas GSFC.BO's P/E ratio is 8.31. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to GSFC.BO's ROE of +0.06%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to GSFC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check GSFC.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, PICCADIL.BO has a market cap of 51B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while PICCADIL.BO trades at ₹541.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas PICCADIL.BO's P/E ratio is 37.46. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to PICCADIL.BO's ROE of +0.19%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to PICCADIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check PICCADIL.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, RALLIS.NS has a market cap of 42.4B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while RALLIS.NS trades at ₹233.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas RALLIS.NS's P/E ratio is 25.47. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to RALLIS.NS's ROE of +0.09%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to RALLIS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check RALLIS.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, RALLIS.BO has a market cap of 42.3B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while RALLIS.BO trades at ₹233.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas RALLIS.BO's P/E ratio is 25.38. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to RALLIS.BO's ROE of +0.09%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to RALLIS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check RALLIS.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, DHANUKA.NS has a market cap of 40.5B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while DHANUKA.NS trades at ₹943.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas DHANUKA.NS's P/E ratio is 5.74. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to DHANUKA.NS's ROE of +0.19%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to DHANUKA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check DHANUKA.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, DHANUKA.BO has a market cap of 40.5B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while DHANUKA.BO trades at ₹943.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas DHANUKA.BO's P/E ratio is 5.74. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to DHANUKA.BO's ROE of +0.19%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to DHANUKA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check DHANUKA.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, MBAPL.NS has a market cap of 40.3B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while MBAPL.NS trades at ₹504.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas MBAPL.NS's P/E ratio is 38.56. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to MBAPL.NS's ROE of +0.26%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to MBAPL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check MBAPL.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, KSCL.BO has a market cap of 40.2B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while KSCL.BO trades at ₹830.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas KSCL.BO's P/E ratio is 13.25. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to KSCL.BO's ROE of +0.19%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to KSCL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check KSCL.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, MANGCHEFER.NS has a market cap of 36.6B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while MANGCHEFER.NS trades at ₹308.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas MANGCHEFER.NS's P/E ratio is 22.67. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to MANGCHEFER.NS's ROE of +0.16%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to MANGCHEFER.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check MANGCHEFER.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, MANGCHEFER.BO has a market cap of 36.6B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while MANGCHEFER.BO trades at ₹308.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas MANGCHEFER.BO's P/E ratio is 22.63. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to MANGCHEFER.BO's ROE of +0.16%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to MANGCHEFER.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check MANGCHEFER.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, BNHOLDINGS.BO has a market cap of 34.8B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while BNHOLDINGS.BO trades at ₹355.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas BNHOLDINGS.BO's P/E ratio is 26.71. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to BNHOLDINGS.BO's ROE of +0.18%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to BNHOLDINGS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check BNHOLDINGS.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, NFL.BO has a market cap of 31.7B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while NFL.BO trades at ₹69.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas NFL.BO's P/E ratio is 16.27. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to NFL.BO's ROE of +0.07%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to NFL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check NFL.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, NFL.NS has a market cap of 31.7B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while NFL.NS trades at ₹69.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas NFL.NS's P/E ratio is 16.25. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to NFL.NS's ROE of +0.07%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to NFL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check NFL.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, KRISHANA.NS has a market cap of 29.1B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while KRISHANA.NS trades at ₹498.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas KRISHANA.NS's P/E ratio is 22.38. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to KRISHANA.NS's ROE of +0.34%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to KRISHANA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check KRISHANA.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, NACLIND.NS has a market cap of 24.6B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while NACLIND.NS trades at ₹131.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas NACLIND.NS's P/E ratio is -61.73. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to NACLIND.NS's ROE of -0.10%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to NACLIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check NACLIND.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, NACLIND.BO has a market cap of 24.4B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while NACLIND.BO trades at ₹130.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas NACLIND.BO's P/E ratio is -61.28. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to NACLIND.BO's ROE of -0.10%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to NACLIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check NACLIND.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, VENKYS.BO has a market cap of 24.2B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while VENKYS.BO trades at ₹1,714.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas VENKYS.BO's P/E ratio is -57.49. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to VENKYS.BO's ROE of +0.04%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to VENKYS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check VENKYS.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, KSE.NS has a market cap of 22.3B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while KSE.NS trades at ₹697.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas KSE.NS's P/E ratio is N/A. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to KSE.NS's ROE of +0.41%. Regarding short-term risk, RJBIOTECH.BO and KSE.NS have similar daily volatility (0.00).Check KSE.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, BHAGCHEM.NS has a market cap of 22.2B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while BHAGCHEM.NS trades at ₹195.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas BHAGCHEM.NS's P/E ratio is 169.77. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to BHAGCHEM.NS's ROE of +0.02%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to BHAGCHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check BHAGCHEM.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, BHAGCHEM.BO has a market cap of 22.2B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while BHAGCHEM.BO trades at ₹194.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas BHAGCHEM.BO's P/E ratio is 169.60. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to BHAGCHEM.BO's ROE of +0.02%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to BHAGCHEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check BHAGCHEM.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, CIANAGRO.BO has a market cap of 21B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while CIANAGRO.BO trades at ₹713.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas CIANAGRO.BO's P/E ratio is 18.70. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to CIANAGRO.BO's ROE of +0.08%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to CIANAGRO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check CIANAGRO.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, INSECTICID.BO has a market cap of 15.5B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while INSECTICID.BO trades at ₹582.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas INSECTICID.BO's P/E ratio is 10.91. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to INSECTICID.BO's ROE of +0.13%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to INSECTICID.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check INSECTICID.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, INSECTICID.NS has a market cap of 15.4B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while INSECTICID.NS trades at ₹582.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas INSECTICID.NS's P/E ratio is 10.83. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to INSECTICID.NS's ROE of +0.13%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to INSECTICID.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check INSECTICID.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, IPL.NS has a market cap of 14.4B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while IPL.NS trades at ₹135.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas IPL.NS's P/E ratio is 13.18. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to IPL.NS's ROE of +0.12%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to IPL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check IPL.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, IPL.BO has a market cap of 14.4B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while IPL.BO trades at ₹134.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas IPL.BO's P/E ratio is 13.15. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to IPL.BO's ROE of +0.12%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to IPL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check IPL.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, ASTEC.NS has a market cap of 12B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while ASTEC.NS trades at ₹557.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas ASTEC.NS's P/E ratio is -12.77. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to ASTEC.NS's ROE of -0.30%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to ASTEC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check ASTEC.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, ASTEC.BO has a market cap of 12B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while ASTEC.BO trades at ₹557.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas ASTEC.BO's P/E ratio is -12.75. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to ASTEC.BO's ROE of -0.30%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to ASTEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check ASTEC.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, SPIC.BO has a market cap of 11.3B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while SPIC.BO trades at ₹60.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas SPIC.BO's P/E ratio is 6.08. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to SPIC.BO's ROE of +0.17%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to SPIC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check SPIC.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, SPIC.NS has a market cap of 11.3B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while SPIC.NS trades at ₹61.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas SPIC.NS's P/E ratio is 5.60. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to SPIC.NS's ROE of +0.17%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to SPIC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check SPIC.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, BHARATRAS.NS has a market cap of 10.1B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while BHARATRAS.NS trades at ₹1,305.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas BHARATRAS.NS's P/E ratio is 15.15. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to BHARATRAS.NS's ROE of +0.12%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to BHARATRAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check BHARATRAS.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, BHARATRAS.BO has a market cap of 10B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while BHARATRAS.BO trades at ₹1,304.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas BHARATRAS.BO's P/E ratio is 15.07. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to BHARATRAS.BO's ROE of +0.12%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to BHARATRAS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check BHARATRAS.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, MOL.NS has a market cap of 9.3B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while MOL.NS trades at ₹42.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas MOL.NS's P/E ratio is 23.11. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to MOL.NS's ROE of +0.03%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to MOL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check MOL.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, MOL.BO has a market cap of 9.3B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while MOL.BO trades at ₹42.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas MOL.BO's P/E ratio is 23.05. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to MOL.BO's ROE of +0.03%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to MOL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check MOL.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, MADRASFERT.BO has a market cap of 8.6B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while MADRASFERT.BO trades at ₹58.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas MADRASFERT.BO's P/E ratio is 118.13. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to MADRASFERT.BO's ROE of -0.53%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to MADRASFERT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check MADRASFERT.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, MADRASFERT.NS has a market cap of 8.5B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while MADRASFERT.NS trades at ₹58.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas MADRASFERT.NS's P/E ratio is 117.91. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to MADRASFERT.NS's ROE of -0.53%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to MADRASFERT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check MADRASFERT.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, BLUECLOUDS.BO has a market cap of 8.3B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while BLUECLOUDS.BO trades at ₹19.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas BLUECLOUDS.BO's P/E ratio is 13.46. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to BLUECLOUDS.BO's ROE of +0.49%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to BLUECLOUDS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check BLUECLOUDS.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, DHARMAJ.NS has a market cap of 7.8B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while DHARMAJ.NS trades at ₹237.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas DHARMAJ.NS's P/E ratio is 16.14. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to DHARMAJ.NS's ROE of +0.12%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to DHARMAJ.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check DHARMAJ.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, DHARMAJ.BO has a market cap of 7.8B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while DHARMAJ.BO trades at ₹235.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas DHARMAJ.BO's P/E ratio is 16.15. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to DHARMAJ.BO's ROE of +0.12%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to DHARMAJ.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check DHARMAJ.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, ZUARI.NS has a market cap of 7.6B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while ZUARI.NS trades at ₹196.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas ZUARI.NS's P/E ratio is 0.79. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to ZUARI.NS's ROE of +0.41%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to ZUARI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check ZUARI.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, BAJAJST.BO has a market cap of 6.4B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while BAJAJST.BO trades at ₹337.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas BAJAJST.BO's P/E ratio is 12.27. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to BAJAJST.BO's ROE of +0.14%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to BAJAJST.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check BAJAJST.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, BSHSL.NS has a market cap of 6.4B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while BSHSL.NS trades at ₹72.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas BSHSL.NS's P/E ratio is 22.65. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to BSHSL.NS's ROE of +0.25%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to BSHSL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check BSHSL.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, HERANBA.NS has a market cap of 6.3B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while HERANBA.NS trades at ₹173.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas HERANBA.NS's P/E ratio is -10.48. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to HERANBA.NS's ROE of -0.07%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to HERANBA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check HERANBA.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, HERANBA.BO has a market cap of 6.3B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while HERANBA.BO trades at ₹173.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas HERANBA.BO's P/E ratio is -10.46. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to HERANBA.BO's ROE of -0.07%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to HERANBA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check HERANBA.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, SHINDL.BO has a market cap of 5.8B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while SHINDL.BO trades at ₹152.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas SHINDL.BO's P/E ratio is 46.75. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to SHINDL.BO's ROE of +0.12%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to SHINDL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check SHINDL.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, SVRL.BO has a market cap of 5.7B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while SVRL.BO trades at ₹284.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas SVRL.BO's P/E ratio is 22.58. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to SVRL.BO's ROE of +0.21%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to SVRL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check SVRL.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, KSE.BO has a market cap of 5.6B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while KSE.BO trades at ₹180.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas KSE.BO's P/E ratio is 4.60. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to KSE.BO's ROE of +0.41%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to KSE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check KSE.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, BESTAGRO.BO has a market cap of 4.4B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while BESTAGRO.BO trades at ₹12.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas BESTAGRO.BO's P/E ratio is 6.56. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to BESTAGRO.BO's ROE of +0.03%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to BESTAGRO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check BESTAGRO.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, BESTAGRO.NS has a market cap of 4.4B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while BESTAGRO.NS trades at ₹12.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas BESTAGRO.NS's P/E ratio is 6.54. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to BESTAGRO.NS's ROE of +0.03%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to BESTAGRO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check BESTAGRO.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, KNAGRI.NS has a market cap of 4.3B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while KNAGRI.NS trades at ₹180.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas KNAGRI.NS's P/E ratio is 11.72. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to KNAGRI.NS's ROE of N/A. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to KNAGRI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check KNAGRI.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, ARIES.NS has a market cap of 4.2B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while ARIES.NS trades at ₹340.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas ARIES.NS's P/E ratio is 9.68. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to ARIES.NS's ROE of +0.15%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to ARIES.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check ARIES.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, KHAICHEM.NS has a market cap of 4.2B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while KHAICHEM.NS trades at ₹48.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas KHAICHEM.NS's P/E ratio is 5.83. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to KHAICHEM.NS's ROE of +0.31%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to KHAICHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check KHAICHEM.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, KHAICHEM.BO has a market cap of 4.2B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while KHAICHEM.BO trades at ₹48.66.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas KHAICHEM.BO's P/E ratio is 5.82. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to KHAICHEM.BO's ROE of +0.31%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to KHAICHEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check KHAICHEM.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, MODINATUR.BO has a market cap of 3.8B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while MODINATUR.BO trades at ₹302.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas MODINATUR.BO's P/E ratio is 9.80. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to MODINATUR.BO's ROE of +0.32%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to MODINATUR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check MODINATUR.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, IGCL.NS has a market cap of 3.7B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while IGCL.NS trades at ₹62.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas IGCL.NS's P/E ratio is 10.67. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to IGCL.NS's ROE of +0.12%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to IGCL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check IGCL.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, RAMAPHO.NS has a market cap of 3.7B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while RAMAPHO.NS trades at ₹112.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas RAMAPHO.NS's P/E ratio is 7.01. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to RAMAPHO.NS's ROE of +0.14%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to RAMAPHO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check RAMAPHO.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, RAMAPHO.BO has a market cap of 3.7B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while RAMAPHO.BO trades at ₹112.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas RAMAPHO.BO's P/E ratio is 6.98. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to RAMAPHO.BO's ROE of +0.14%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to RAMAPHO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check RAMAPHO.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, SHIVALIK.NS has a market cap of 3.5B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while SHIVALIK.NS trades at ₹233.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas SHIVALIK.NS's P/E ratio is 29.93. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to SHIVALIK.NS's ROE of +0.02%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to SHIVALIK.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check SHIVALIK.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, MISHTANN.BO has a market cap of 3.2B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while MISHTANN.BO trades at ₹3.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas MISHTANN.BO's P/E ratio is 0.96. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to MISHTANN.BO's ROE of +0.35%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to MISHTANN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check MISHTANN.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, GOODRICKE.BO has a market cap of 3.2B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while GOODRICKE.BO trades at ₹148.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas GOODRICKE.BO's P/E ratio is 17.46. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to GOODRICKE.BO's ROE of +0.06%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to GOODRICKE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check GOODRICKE.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, KINGSINFR.BO has a market cap of 2.8B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while KINGSINFR.BO trades at ₹121.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas KINGSINFR.BO's P/E ratio is 20.47. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to KINGSINFR.BO's ROE of +0.19%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to KINGSINFR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check KINGSINFR.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, NATHBIOGEN.NS has a market cap of 2.5B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while NATHBIOGEN.NS trades at ₹137.46.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas NATHBIOGEN.NS's P/E ratio is 5.69. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to NATHBIOGEN.NS's ROE of +0.07%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to NATHBIOGEN.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check NATHBIOGEN.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, NATHBIOGEN.BO has a market cap of 2.4B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while NATHBIOGEN.BO trades at ₹139.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas NATHBIOGEN.BO's P/E ratio is 5.63. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to NATHBIOGEN.BO's ROE of +0.07%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to NATHBIOGEN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check NATHBIOGEN.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, NAGAFERT.BO has a market cap of 2.1B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while NAGAFERT.BO trades at ₹3.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas NAGAFERT.BO's P/E ratio is -7.50. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to NAGAFERT.BO's ROE of +0.03%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to NAGAFERT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check NAGAFERT.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, NAGAFERT.NS has a market cap of 2.1B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while NAGAFERT.NS trades at ₹3.67.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas NAGAFERT.NS's P/E ratio is -7.32. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to NAGAFERT.NS's ROE of +0.03%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to NAGAFERT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check NAGAFERT.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, INDOUS.NS has a market cap of 2B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while INDOUS.NS trades at ₹101.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas INDOUS.NS's P/E ratio is 13.27. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to INDOUS.NS's ROE of +0.18%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to INDOUS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check INDOUS.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, INDOUS.BO has a market cap of 2B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while INDOUS.BO trades at ₹103.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas INDOUS.BO's P/E ratio is 13.23. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to INDOUS.BO's ROE of +0.19%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to INDOUS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check INDOUS.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, HOACFOODS.NS has a market cap of 1.7B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while HOACFOODS.NS trades at ₹382.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas HOACFOODS.NS's P/E ratio is 56.48. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to HOACFOODS.NS's ROE of N/A. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to HOACFOODS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check HOACFOODS.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, NOVAAGRI.NS has a market cap of 1.7B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while NOVAAGRI.NS trades at ₹22.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas NOVAAGRI.NS's P/E ratio is 9.59. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to NOVAAGRI.NS's ROE of +0.08%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to NOVAAGRI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check NOVAAGRI.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, EQUIPPP.NS has a market cap of 1.5B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while EQUIPPP.NS trades at ₹14.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas EQUIPPP.NS's P/E ratio is 210.29. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to EQUIPPP.NS's ROE of +0.23%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to EQUIPPP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check EQUIPPP.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, EQUIPPP.BO has a market cap of 1.5B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while EQUIPPP.BO trades at ₹14.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas EQUIPPP.BO's P/E ratio is 208.29. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to EQUIPPP.BO's ROE of +0.23%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to EQUIPPP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check EQUIPPP.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, SPTRSHI.BO has a market cap of 1.4B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while SPTRSHI.BO trades at ₹41.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas SPTRSHI.BO's P/E ratio is 45.90. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to SPTRSHI.BO's ROE of +0.25%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to SPTRSHI.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check SPTRSHI.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, SBECSUG.BO has a market cap of 1.4B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while SBECSUG.BO trades at ₹30.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas SBECSUG.BO's P/E ratio is -5.46. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to SBECSUG.BO's ROE of +0.33%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to SBECSUG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check SBECSUG.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, RBS.NS has a market cap of 1.4B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while RBS.NS trades at ₹69.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas RBS.NS's P/E ratio is 8.88. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to RBS.NS's ROE of N/A. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to RBS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check RBS.NS's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, VIJSOLX.BO has a market cap of 1.3B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while VIJSOLX.BO trades at ₹448.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas VIJSOLX.BO's P/E ratio is 8.81. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to VIJSOLX.BO's ROE of +0.04%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to VIJSOLX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check VIJSOLX.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, SSLEL.BO has a market cap of 1.3B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while SSLEL.BO trades at ₹258.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas SSLEL.BO's P/E ratio is -5.35. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to SSLEL.BO's ROE of +0.11%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to SSLEL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check SSLEL.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, INDSUCR.BO has a market cap of 1.2B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while INDSUCR.BO trades at ₹73.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas INDSUCR.BO's P/E ratio is 3.03. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to INDSUCR.BO's ROE of +0.16%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to INDSUCR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check INDSUCR.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, MSL.BO has a market cap of 1.2B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while MSL.BO trades at ₹116.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas MSL.BO's P/E ratio is 11.68. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to MSL.BO's ROE of +0.13%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to MSL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check MSL.BO's competition here

RJBIOTECH.BO plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RJBIOTECH.BO stands at 0. In comparison, NARMADA.BO has a market cap of 1.2B. Regarding current trading prices, RJBIOTECH.BO is priced at ₹3.43, while NARMADA.BO trades at ₹32.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RJBIOTECH.BO currently has a P/E ratio of N/A, whereas NARMADA.BO's P/E ratio is 27.47. In terms of profitability, RJBIOTECH.BO's ROE is N/A, compared to NARMADA.BO's ROE of +0.08%. Regarding short-term risk, RJBIOTECH.BO is less volatile compared to NARMADA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for RJBIOTECH.BO.Check NARMADA.BO's competition here